Commentary: FDA Must Overcome Skepticism Toward Health Claims
This article was originally published in The Tan Sheet
Executive Summary
In a guest commentary, regulatory and safety consultant George Burdock discusses his views on the historical developments that shaped FDA’s attitudes toward health claims, and what the agency could do to incentivize greater investment in this area by food and dietary supplement companies.